1213 Development and multiplexing of virtual immuno-oncology biomarkers for enhanced research and discovery
Background The complexity of the tumor microenvironment in immuno-oncology (IO) research necessitates advanced tools for precise biomarker analysis. Our innovative virtual immunohistochemistry (IHC) pipeline has been adapted to develop a comprehensive panel of IO biomarkers, including CD206, CD4, CD8, FOXP3, PD-L1, and...